RESMED INC — Director's Dealing 2013

Feb 27, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-02-25

Reporting Person: ROBERTS CHRISTOPHER G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-25	ResMed Common Stock	S	10000	$43.12	Disposed	292400	Indirect
2013-02-26	ResMed Common Stock	S	10000	$43.2024	Disposed	282400	Indirect
2013-02-27	ResMed Common Stock	S	10000	$43.37	Disposed	272400	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-11-15	ResMed Stock Options	$38.98	A	25934	Acquired	2019-11-15	ResMed Common Stock (25934)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	30000	Direct
ResMed Common Stock	23200	Indirect
ResMed Common Stock	136000	Indirect

Footnotes

F1: Options vest in full (i) on the first Nov. 11 following grant date or (ii) the first annual shareholder's meeting following grant date. Options have a required holding period until the earlier of (i) Nov. 11 of the third year following grant date or (ii) six months following termination of directorship.